Navigation Links
Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting
Date:5/18/2011

WAYNE, N.J. and SOUTH SAN FRANCISCO, May 18, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that data evaluating the use of Nexavar® (sorafenib) tablets will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 3-7, in Chicago.  

"Bayer and Onyx remain committed to researching the potential utility of sorafenib, and the number of abstracts being presented at this year's ASCO is a true testament to this commitment," said Dr. Dimitris Voliotis, Vice President, Global Clinical Development Oncology, Bayer HealthCare. "The companies look forward to continuing to work together, and with various institutions and study groups, to further explore sorafenib.  Sorafenib has demonstrated efficacy in patients with unresectable liver cancer and advanced kidney cancer, and we remain committed to determine the potential of this therapy for patients."

Bayer and Onyx-sponsored, Phase 2 and 3 studies, and other research evaluating sorafenib, including investigational uses, being presented at ASCO include:

Efficacy and safety of intra-patient dose escalation of sorafenib as first-line treatment for metastatic renal cell carcinoma (mRCC)

  • Professor Martin Gore, Medical Director, The Royal Marsden and Professor of Cancer Medicine at The Institute of Cancer Research, United Kingdom
  • Abstract number: 4609
  • June 5, 8:00 am – 12:00 pm, General Poster Session

Sorafenib plus chemotherapy for patients with advanced breast cancer previously treated with bevacizumab.

  • Clifford Hudis, M.D., Memorial Sloan-Kettering Cancer Center
  • Abstract number: 1009
  • June 6, 11:45 am, Oral Abstract Session<
    '/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
2. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
3. Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress
4. Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
5. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
6. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
7. Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
8. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
9. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
10. New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
11. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has ... Tissue Repair Devices Market 2014-2018" report to their ... mass of cells that connect, support, or surround bones. ... as tendons, ligaments, cartilage, fascia, and other fibrous tissues. ... tissues with age result in wear and tear in ...
(Date:8/28/2014)...  Rigrodsky & Long, P.A.: , Do you, ... LCI )? , Did you purchase your shares before ... 2014, inclusive? , Did you lose money in your ... to discuss your rights? Rigrodsky & ... Timothy J. MacFall , announces that a complaint has been filed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... Regado Biosciences, a privately held company leading the ... that Ellen McDonald, MBA, Senior Vice President and Chief ... at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.  Ms. ... on Wednesday, November 10 in the Life Science Room ...
... a biopharmaceutical company focused on the discovery and development ... and chronic viral diseases, announced today that it has ... Project (QTDP) administered under section 48D of the Internal ... innovative projects that are determined by the U.S. Department ...
Cached Medicine Technology:Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 2Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania 3
(Date:8/29/2014)... 2014 Floors of hospitals and other ... socks. Also, many patients are relegated to lying down ... recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, have ... safety. , This special pair of socks helps prevent ... patients who are relegated to beds or chairs from ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... by volunteering are getting more out of it than ... health boost! , A new study, led ... and published online this week in Psychological Bulletin ... at all the available peer-reviewed evidence regarding the psychosocial ... Lead investigator Dr. Nicole Anderson, together with scientists from ...
(Date:8/29/2014)... 29, 2014 University of Western States ... professionals, announced that Daniel Redwood, DC, director of the ... of the Year,” by the Missouri State Chiropractors Association ... 21. , Patrick Montgomery, DC, president of the MSCA, ... the Missouri House Task Force for Medicaid Reform, in ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... on fatty acids conducted at the universities of Helsinki ... the level of fibrinogen detrimental to health in the ... in essential fats in one,s diet, decreases when saturated ... research results were published in the journal Prostaglandins, ...
... HealthDay Reporter , SUNDAY, Nov. 7 (HealthDay News) ... the joints, new research suggests. The autoimmune disorder ... plaque in the blood vessels, potentially increasing the risk of ... news from the study is that certain drugs already used ...
... new study suggests joint complaints attributed to aromatase inhibitors ... inflammatory arthritis or autoimmune disease. Because of that, ... threat of arthritis should be encouraged to continue taking ... presented Tuesday, Nov. 9 at the 74th Annual Scientific ...
... , SUNDAY, Nov. 7 (HealthDay News) -- People suffering from ... taking vitamin D supplements, U.S. researchers report. "I,ve never ... Kevin Dalal, an assistant professor of rehabilitation medicine at the ... surprised it didn,t work. It,s a tough process to try ...
... hospitalised with severe malaria has concluded that the drug ... disease in both children and adults everywhere in the ... published today online in the journal The Lancet ... Professor Nick White of the Wellcome Trust-Mahidol University-Oxford Tropical ...
... 5 (HealthDay News) -- Falls from tree stands are the ... University study. Researchers analyzed 130 hunting-related trauma admissions at ... percent of injuries were caused by falls, and 92 percent ... other findings: , Gunshot wounds accounted for 29 percent ...
Cached Medicine News:Health News:Canola-type rapeseed oil reduces the level of fibrinogen, a cause of thrombosis and inflammation 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 2Health News:Rheumatoid Arthritis May Raise Risk of Blood Vessel Plaque 3Health News:Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease 2Health News:Vitamin D No Magic Bullet for Osteoarthritis 2Health News:Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide 2Health News:Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: